Ovarian cancer peptides (unidentified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ovarian cancer peptides (unidentified), covering 2012-11-19 to 2012-11-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer [Phase 1]